Skip to content

Clinical trials

Overweight trials in Iran with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Not applicable Country / region: Iran Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20155
20161
20177
20191
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novindiet Clinic12
Urmia University of Medical Sciences2
Arya Habibi1
Birjand University of Medical Sciences1
Shahid Beheshti University1
Shahid Beheshti University of Medical Sciences1
Shiraz University of Medical Sciences1
Tirang R. Neyestani, Ph.D.1
University of Tehran1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight21
Obesity20
Weight Loss10
Insulin Resistance3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Hypertriglyceridemia2
Vitamin D Deficiency1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.